Exozymes Inc. (EXOZ) income statement
EXOZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.90−0.48 (-14.05%)
Close on Nov 20, 2026Market cap $26.96MP/E –Yield –
Exozymes Inc. financial ratios
See a number that looks wrong?